GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled TrialsLesley A. Inker, Tom Greene, Philip Kam‐Tao Li et al.|Journal of the American Society of Nephrology|2019Cited by 295